Roosevelt Sousa Has a 3-Year IBJJF Ban for Meldonium. He's Still Challenging For The UFC BJJ Title.

When Roosevelt Sousa steps onto the mats for UFC's inaugural BJJ championship next month, he'll be doing so under a cloud of controversy that perfectly encapsulates the fractured state of competitive grappling governance. The Brazilian heavyweight is currently serving a 3-year IBJJF suspension for testing positive for meldonium in 2025 — a ban that somehow doesn't prevent him from competing under the UFC banner. Because in the Wild West of professional jiu-jitsu, which sanctioning body's rules apply depends entirely on who's writing the checks that week.

The IBJJF announced Sousa's suspension last November after he tested positive for the banned substance following his gold medal performance at the 2025 Pan Championships. Meldonium, the same drug that got Maria Sharapova suspended from tennis, is prohibited year-round under IBJJF rules as a metabolic modulator. Sousa claimed the positive test resulted from medication he took for a heart condition — an explanation the IBJJF apparently found as convincing as a white belt's 'I was just resting' defense when caught in a triangle choke.

Yet here we are, seven months into his IBJJF exile, with Sousa preparing to challenge for what UFC is billing as its first official BJJ world title. The promotion has remained conspicuously silent about Sousa's suspension, treating it with the same indifference as a blue belt ignoring positional hierarchy during a roll. When pressed by reporters, UFC officials offered the standard 'different organizations have different policies' non-answer — which roughly translates to 'we don't care as long as it doesn't affect our PPV buys.'

This isn't Sousa's first doping controversy either. The 32-year-old previously served a 6-month suspension in 2021 for diuretic use, proving that when it comes to banned substances, he's got the consistency of a wrestler who insists they 'just want to work takedowns' before immediately pulling guard. What makes this situation particularly absurd is that UFC has one of the most robust anti-doping programs in combat sports through USADA — except, apparently, when it comes to their new BJJ venture.

The grappling community's response has been predictably mixed. Some argue the IBJJF's punishment is excessive (their anti-doping policy is notably stricter than most other grappling organizations). Others point out that if Sousa genuinely needed meldonium for medical reasons, he could have — and should have — applied for a therapeutic use exemption. Then there's the faction that simply shrugs and says 'at least he's not hiding knee reaps,' because in 2026, that apparently counts as moral high ground.

What this situation really exposes is the complete lack of unified standards in professional grappling. An athlete can be simultaneously banned and celebrated depending on which organization's logo appears on the mats. It's the competitive equivalent of getting your black belt at one gym only to have the academy across town make you start over as a white belt — except with more pharmaceuticals and fewer awkward belt-tying demonstrations.

As Sousa prepares for his title shot, the only certainty is this: whether he wins or loses, the real loser here is any semblance of consistent anti-doping enforcement in professional jiu-jitsu. But hey, at least we'll get to see if his cardio holds up in later rounds without whatever heart medication got him into this mess in the first place.

This post was generated by AI. Sources are linked below. Follow @bjj-problems on YouTube for the weekly video digest.

Sources

• IBJJF announces Roosevelt Sousa's 3-year suspension for meldonium
• UFC confirms Sousa's participation in inaugural BJJ championship